Sort by:

select Language:



Epilepsy mhGAP Training of Health-care Providers Training manual Supporting material

World Health Organization WHO, (2019)


mhGAP Training Manual for the mhGAP Intervention Guide for mental, neurological and substance use disorders in non-specialized health settings – version 2.0 (for field testing)
https://www.who.int/mental_health/mhgap/epi_suppor...


EPI 1: Antiepileptic medications for management of acute convulsive seizures when no intravenous access is available

World Health Organization WHO, (2015)


[Updated 2015] Scoping Question: In adults with acute convulsive seizures in first-level care or in the community (when no IV access is available), which antiepileptic medications produce benefits and/or harm when compared to comparator?
https://www.who.int/mental_health/mhgap/evidence/r...


EPI 4: Antiepileptic medications for adults and children with HIV

World Health Organization WHO, (2015)


Scoping Question: For adults and children living with HIV, which antiepileptic medications (such as phenobarbital, phenytoin, carbamazepine or valproic acid) produce benefits and/or harms when compared to a placebo or controls?
https://www.who.int/mental_health/mhgap/evidence/r...


Management of febrile seizures

World Health Organization WHO, (2012)


Q3: Can febrile seizures (simple or complex) be managed at first or second level care by non-specialist health care providers in low and middle income country settings? What is the role of diagnostic tests in the management of febrile seizures by non-specialists in low and middle income settings? For prophylaxis to prevent recurrence of simple or complex febrile seizures, which of the pharmacological interventions when compared with placebo/comparator produce benefit/harm in specified outcomes? - continuous anticonvulsant therapy - intermittent anticonvulsant therapy - intermittent antipyretic treatment
https://www.who.int/mental_health/mhgap/evidence/r...


Role of EEG in management of convulsive epilepsy

World Health Organization WHO, (2012)


Q5: What is the added advantage of doing an electroencephalography (EEG) in people with convulsive epilepsy in non- specialist settings in low and middle income countries?
https://www.who.int/mental_health/mhgap/evidence/r...


Diagnosis of convulsive epilepsy by non-specialist health care providers

World Health Organization WHO, (2012)


Q4: Can convulsive epilepsy be diagnosed at first level care by a non-specialist health care provider in low and middle income country settings?
https://www.who.int/mental_health/mhgap/evidence/r...


Psychological interventions in adults and children with epilepsy

World Health Organization WHO, (2012)


Q 10: In adults and children with epilepsy, which psychological interventions used as adjunctive therapies with antiepileptic drugs when compared to placebo/comparator produce benefits/harm in specified outcomes?
https://www.who.int/mental_health/mhgap/evidence/r...


When to discontinue antiepileptic drug treatment in adults and children

World Health Organization WHO, (2012)


Q9. In adults and children with convulsive epilepsy in remission, when should treatment be discontinued?
https://www.who.int/mental_health/mhgap/evidence/r...


Role of neuroimaging in management of convulsive epilepsy

World Health Organization WHO, (2012)


Q6: What is the added advantage of doing neuroimaging in people with convulsive epilepsy in non-specialist settings in low and middle income countries?
https://www.who.int/mental_health/mhgap/evidence/r...


Оценка и лечение состояний, связанных исключительно со стрессом _ Руководства mhGAP по принятию мер в отношении психических и неврологических расстройств

World Health Organization, Eds.: World Health Organization, (2015)


В этом разделе «Руководства mhGAP по принятию мер в отношении психических и неврологических расстройств» приведены рекомендации по оценке и оказанию помощи при остром стрессовом расстройстве, посттравматическом стрессовом расстройстве и горе в неспециализированных медицинских учреждениях. Он представляет собой приложение к «Руководству mhGAP попринятию мер в отношении психических и не- врологических расстройств и расстройств, связанных с употреблением наркотиков и других веществ, в неспециализированных медицинских учреждениях» (ВОЗ, 2010 г.). Руководящие принципы, отраженные в этом разделе, основаны на официально утвержденных рекомендациях группы по разработке руководства ВОЗ.
https://apps.who.int/iris/bitstream/handle/10665/8...


62 hits